Oxipit

📍 Vilnius, Lithuania🗓 Founded 2017👥 21 employees💰 Last funded Apr 2025
Since 2017, Oxipit has been building radiology AI you can trust—tools that analyze chest X-rays, support faster diagnoses, and ease the workload for clinical teams. As imaging volumes rise and pressure on radiology departments grows, our mission is clear: reduce the burden, support precision, and help radiologists focus on what matters most. Oxipits CXR Suite is a certified, powerful portfolio of radiology AI tools designed to streamline chest X-ray diagnostics from start to finish. Trusted by healthcare institutions globally, the CXR Suite brings together three advanced solutions: • ChestLink – the world’s first autonomous AI for normal chest X-rays, safely removing up to 40% of studies from radiologists’ workloads with 99.9% sensitivity. • ChestEye – an on-screen assistant that detects 75 findings, supporting diagnostic quality and day-to-day decision-making. • ChestQuality – a second set of eyes—continuously reviewing reports to support accuracy and catch overlooked findings. No matter where you are in your AI journey, the Oxipit CXR Suite meets you there. Start with the tools that fit your needs today—and scale as your workflow evolves. The future of radiology AI is flexible—and autonomous.
6
Total investors
2
Early stage
0
Mid stage
4
Late stage
2017
Founded
Investor geography2 countries
Lithuania
5
United Kingdom
1
Investor activity2019–2025 · investors recorded per year
201922024220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Oxipit?
Oxipit has 6 investors on record on gritt.io, including 2 early-stage backers and 4 late-stage investors.
When did Oxipit last raise funding?
The most recent investment in Oxipit recorded on gritt.io was in April 2025.
When was Oxipit founded?
Oxipit was founded in 2017.
What industry is Oxipit in?
Oxipit operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Oxipit based?
Oxipit is headquartered in Vilnius, Lithuania.